Table 4.
Results of Poisson regression analysis evaluating the association between the regional availability of high dose rate brachytherapy (HDR‐BT) services and whether men with high‐risk and locally advanced prostate cancer who received radical radiotherapy also received HDR‐BT (n = 12,835).1
| HDR‐BT (%) | Adjusted RR | 95% CI | P 2 | ||||
|---|---|---|---|---|---|---|---|
| HDR‐BT available | <0.01 | ||||||
| No | 1.2 | 1 | |||||
| Yes | 7.7 | 6.16 | 2.94 | ‐ | 12.92 | ||
1
Adjusted for age, ethnicity, socioeconomic deprivation status, RCS Charlson co‐morbidity score, T stage, N stage, Gleason score, and PSA.
2
Wald test.